Kino Y - Search Results

1

Clinical phase II and III studies of an AS03-adjuvanted H5N1 influenza vaccine produced in an EB66^® cell culture platform.

Endo M, Tanishima M, Ibaragi K, Hayashida K, Fukuda T, Tanabe T, Naruse T, Kino Y, Ueda K. Endo M, et al. Among authors: kino y. Influenza Other Respir Viruses. 2020 Sep;14(5):551-563. doi: 10.1111/irv.12755. Epub 2020 Jun 24. Influenza Other Respir Viruses. 2020. PMID: 32579785 Free PMC article. Clinical Trial.

2

A clinical phase I study of an EB66 cell-derived H5N1 pandemic vaccine adjuvanted with AS03.

Naruse T, Fukuda T, Tanabe T, Ichikawa M, Oda Y, Tochihara S, Kimachi K, Kino Y, Ueda K. Naruse T, et al. Among authors: kino y. Vaccine. 2015 Nov 9;33(45):6078-84. doi: 10.1016/j.vaccine.2015.09.022. Epub 2015 Sep 25. Vaccine. 2015. PMID: 26409141 Clinical Trial.

3

Phase II and III Clinical Studies of Diphtheria-Tetanus-Acellular Pertussis Vaccine Containing Inactivated Polio Vaccine Derived from Sabin Strains (DTaP-sIPV).

Okada K, Miyazaki C, Kino Y, Ozaki T, Hirose M, Ueda K. Okada K, et al. Among authors: kino y. J Infect Dis. 2013 Jul 15;208(2):275-83. doi: 10.1093/infdis/jit155. Epub 2013 Apr 8. J Infect Dis. 2013. PMID: 23568174 Clinical Trial.

4

Immunogenicity and safety of an inactivated quadrivalent influenza vaccine in healthy adults: a phase II, open-label, uncontrolled trial in Japan.

Tsurudome Y, Kimachi K, Okada Y, Matsuura K, Ooyama Y, Ibaragi K, Kino Y, Ueda K. Tsurudome Y, et al. Among authors: kino y. Microbiol Immunol. 2015 Oct;59(10):597-604. doi: 10.1111/1348-0421.12316. Microbiol Immunol. 2015. PMID: 26272602 Free article. Clinical Trial.

5

Effect of prior vaccination with a seasonal trivalent influenza vaccine on the antibody response to the influenza pandemic H1N1 2009 vaccine: a randomized controlled trial.

Uno S, Kimachi K, Kei J, Miyazaki K, Oohama A, Nishimura T, Ibaragi K, Odoh K, Kudo Y, Kino Y. Uno S, et al. Among authors: kino y. Microbiol Immunol. 2011 Nov;55(11):783-9. doi: 10.1111/j.1348-0421.2011.00381.x. Microbiol Immunol. 2011. PMID: 21895745 Free article. Clinical Trial.

6

Immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1, NIBRG-14) vaccine administered by intramuscular or subcutaneous injection.

Ikeno D, Kimachi K, Kino Y, Harada S, Yoshida K, Tochihara S, Itamura S, Odagiri T, Tashiro M, Okada K, Miyazaki C, Ueda K. Ikeno D, et al. Among authors: kino y. Microbiol Immunol. 2010 Feb;54(2):81-8. doi: 10.1111/j.1348-0421.2009.00191.x. Microbiol Immunol. 2010. PMID: 20377741 Free article. Clinical Trial.

7

Differences in the priming effect of various clades/subclades of inactivated H5N1 vaccine for booster injection with heterologous clades of vaccine strains.

Ikeno D, Kimachi K, Ibaragi K, Kudo Y, Goto S, Odoh K, Itamura S, Odagiri T, Tashiro M, Kino Y. Ikeno D, et al. Among authors: kino y. Vaccine. 2011 May 31;29(24):4156-61. doi: 10.1016/j.vaccine.2011.03.084. Epub 2011 Apr 15. Vaccine. 2011. PMID: 21497637

8

Non-clinical and phase I clinical trials of a Vero cell-derived inactivated Japanese encephalitis vaccine.

Kuzuhara S, Nakamura H, Hayashida K, Obata J, Abe M, Sonoda K, Nishiyama K, Sugawara K, Takeda K, Honda T, Matsui H, Shigaki T, Kino Y, Mizokami H, Tanaka M, Mizuno K, Ueda K. Kuzuhara S, et al. Among authors: kino y. Vaccine. 2003 Nov 7;21(31):4519-26. doi: 10.1016/s0264-410x(03)00506-1. Vaccine. 2003. PMID: 14575762 Clinical Trial.

9

Duration of neutralizing antibody titer after Japanese encephalitis vaccination.

Abe M, Okada K, Hayashida K, Matsuo F, Shiosaki K, Miyazaki C, Ueda K, Kino Y. Abe M, et al. Among authors: kino y. Microbiol Immunol. 2007;51(6):609-16. doi: 10.1111/j.1348-0421.2007.tb03947.x. Microbiol Immunol. 2007. PMID: 17579272 Free article.

10

Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 induction is ideal for influenza.

Sekiya T, Mifsud EJ, Ohno M, Nomura N, Sasada M, Fujikura D, Daito T, Shingai M, Ohara Y, Nishimura T, Endo M, Mitsumata R, Ikeda T, Hatanaka H, Kitayama H, Motokawa K, Sobue T, Suzuki S, Itoh Y, Brown LE, Ogasawara K, Kino Y, Kida H. Sekiya T, et al. Among authors: kino y. Vaccine. 2019 Apr 3;37(15):2158-2166. doi: 10.1016/j.vaccine.2019.02.057. Epub 2019 Mar 8. Vaccine. 2019. PMID: 30857932

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

181 results

Search Page